Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 02, 2015 9:19 PM ET


Company Overview of Spark Therapeutics, Inc.

Executive Profile

Stephen W. Webster

Chief Financial Officer, Spark Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Stephen W. Webster has been the Chief Financial Officer at Spark Therapeutics Inc. since July 2014 and served as the Chief Financial Officer and Senior Vice President of Optimer Pharmaceuticals, Inc. since June 5, 2012 until 2013 and served as its Principal Accounting Officer and Senior Vice President of Finance. Mr. Webster serves as Managing Director of Gleacher & Company Securities, Inc. Mr. Webster served as Managing Director of First Albany Corporation since ...

Corporate Headquarters

3737 Market Street
Philadelphia, Pennsylvania 19104

United States

Phone: 888-772-7560
Fax: --

Board Members Memberships

Non-Employee Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


Dartmouth College
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

Total Annual Compensation$147,528

Stocks Options

Restricted Stock Awards$481,494
All Other Compensation$12,861
Unexercisable Options$186,015
Total Number of Options$186,015

Total Compensation

Total Annual Cash Compensation$212,889
Total Short Term Compensation$147,528
Other Long Term Compensation$494,355
Total Calculated Compensation$694,383

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
Jörn Aldag Chief Executive Officer, Managing Director and Member of Management Board
uniQure N.V.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Spark Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at